Nailfold microscope study for pulmonary hypertension
Part of Heart & circulation, Lungs & breathing clinical trials.
This study uses a special microscope to look at the tiny blood vessels at the base of your fingernails. It aims to see if these vessels can help doctors understand and monitor pulmonary hypertension, a condition of high blood pressure in the lungs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with or are being checked for pulmonary hypertension (groups 1, 3, or 4).
- You are about to start or increase a treatment for pulmonary hypertension, such as a PDE5 inhibitor, ERA, prostanoid, selexipag, riociguat, or sotatercept.
- You are not already on the maximum treatment for your condition.
- You can have your nailbed examined (no severe hand injuries or conditions preventing this).
- You have not had caffeine or nicotine in the last 4 to 6 hours, and no nail polish or extensions on your nails.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks natural changes in “biomarkers” (measurable signals in blood) and imaging findings in people with pulmonary arterial hypertension (PAH) or suspected PAH. It also includes healthy people for comparison, helping researchers understand what these signals mean over time.
This trial studies tiny particles in your blood (extracellular vesicles) to see if they can predict who will develop blood vessel complications or how they respond to treatment. It focuses on people with systemic sclerosis who currently have a low risk of pulmonary hypertension.
This observational study is looking at people diagnosed with pulmonary hypertension to better understand how it behaves over time. You may help researchers by allowing repeated check-ins for years and sharing symptom and test information.
This is a long-term study that enrolls people who have been diagnosed with pulmonary hypertension (high blood pressure in the lung arteries). It collects medical information over time to better understand the condition and what to expect.
This study looks at how hormones, metabolism, and body signals relate to pulmonary arterial hypertension. You may be eligible if you (or a family member) have idiopathic, inherited, or related pulmonary arterial hypertension, and you can do required blood and other testing.
This trial uses special ultrasound imaging to look at how well the heart works in people newly diagnosed with pulmonary arterial hypertension (PAH). It aims to understand heart changes before and after starting PAH treatment.
Hear when a new Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.